Sumi, Eriko http://orcid.org/0000-0002-5028-0499
Nomura, Takashi
Asada, Ryuta
Uozumi, Ryuji
Tada, Harue
Amino, Yoko
Sawada, Teruo
Yonezawa, Atsushi
Hagiwara, Masatoshi
Kabashima, Kenji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (Translational Research Network Program)
KinoPharma Inc.
Article History
First Online: 4 October 2018
Compliance with Ethical Standards
:
: This was an investigator-initiated study and was financially supported by the Translational Research Network Program of the Japan Agency for Medical Research and Development (AMED) and KinoPharma Inc. (Tokyo, Japan). The funders did not contribute to data collection, analysis, this report, or the decision to publish.
: MH owns equity in and is a scientific advisor of KinoPharma, Inc. The other authors declare that they have no competing interests.
: All procedures performed in studies involving human participants were in accordance with study protocol, the Ministerial Ordinance on GCP for Drugs, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol (code FIT-039-001) was approved by the IRB at Kyoto University Hospital on 12 February 2016 (K025) and the Pharmaceuticals and Medical Devices Agency (PMDA).
: Informed consent was obtained from all individual participants included in the study.